Tranexamic Acid 1197-18-8 Bp High Quality

Model NO.
C8H15NO2
EINECS
214-818-2
Appearance
Powder
Quality
Refined
Colour
White
Loss on Drying
0.30%
Heavy Metals
<10ppm
Transport Package
Express Way as The Following Is: (Shipping: TNT,
Specification
Assay 99.8%
Trademark
JINLAN PHARM
Origin
China
Production Capacity
10000kg/Year
Reference Price
Please contact us for quote
Contact Us

Product Description


Hangzhou Jinlan Pharm-Drugs Technology Co. Ltd.(JL Pharm) is an advanced pharmaceutical corporation with  a laboratory of 1200 square meters in Nanjing city, and cooperative GMP production plants in Beljing, Jiangsu, Zhejiang, Jiangxi, Chengdrand Shandong.We can provide both CDMO technology research and development services, and a ful range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to globapharmaceutical companies during which synthetic route research and development, process reearch and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.
 

Tranexamic Acid 1197-18-8 Bp High Quality Tranexamic Acid 1197-18-8 Bp High Quality
 
Packaging & Shipping

Tranexamic Acid 1197-18-8 Bp High Quality
 

Tranexamic Acid 1197-18-8 Bp High Quality
Product Description
Product Name: Tranexamic Acid
Synonyms: TIMTEC-BB SBB006715;TRANS-4-AMINOMETHYL-1-CYCLOHEXANECARBOXYLIC ACID;trans-4-aminomethylcyclohexane-1-carboxylate;TRANS-4-(AMINOMETHYL)CYCLOHEXANECARBOXYLIC ACID;cyclocapron;cyklokapron;dv-79;emorhalt
CAS: 1197-18-8
MF: C8H15NO2
MW: 157.21
EINECS: 214-818-2
Product Categories: Pharmaceutical intermediates ; API's ; 4-Substituted Cyclohexanecarboxylic Acids ; Amines ; Chiral Reagents ; Intermediates & Fine Chemicals ; Pharmaceuticals ; Building Blocks ; C8 ; API ; CYKLOKAPRON ; Cosmetics ; Hemostatic ; Pharmaceutical raw materials ; Carbonyl Compounds ; Carboxylic Acids ; Chemical Synthesis ; Organic Building Blocks ; 1197-18-8
Mol File: 1197-18-8.mol
 
Tranexamic Acid Chemical Properties
 
Installation Instructions
  
Safety Information
 
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36-37/39
WGK Germany  2
RTECS  GU8400000
HazardClass  IRRITANT
HS Code  29224999
Toxicity LD50 in mice, rats (mg/kg): 1500, 1200 i.v. (Melander)
 
Uses Fibrinolysis, the cleavage of fibrin by plasmin, is a normal step in the dissolution of fibrin clots after wound repair. Tranexamic acid is an inhibitor of fibrinolysis that blocks the interaction of plasmin with fibrin (IC50 = 3.1 μM). It is a lysine mimetic that binds the lysine binding site in plasmin. Antifibrinolytic agents have value when fibrinolytic activity is abnormally high or when coagulation is impaired.



 

Leave Your Message

 

Organic Intermediate
✉ Contact Supplier